Tag archive for ‘Prolor Biotech Inc.’
OPKO
Gali Weinreb On Tuesday, March 4th, 2014

Opko Health Losses Triple

– Chairman and CEO Phillip Frost: From an R&D perspective, all our programs are progressing. – – – Opko Health Inc. (NYSE: OPK; TASE: OPK) reported higher full-year and fourth More...

Wordpress site Developed by Fixing WordPress Problems